Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674375 | SCV000799700 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 2; Usher syndrome type 1 | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002544671 | SCV003439858 | uncertain significance | not provided | 2022-08-22 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1133 of the MYO7A protein (p.Gly1133Arg). This variant is present in population databases (rs782313913, gnomAD 0.01%). This missense change has been observed in individual(s) with MYO7A-related conditions (PMID: 28968992, 30358468). ClinVar contains an entry for this variant (Variation ID: 558149). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYO7A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |